These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35218467)

  • 1. ATGL deficiency aggravates pressure overload-triggered myocardial hypertrophic remodeling associated with the proteasome-PTEN-mTOR-autophagy pathway.
    Han X; Zhang YL; Lin QY; Li HH; Guo SB
    Cell Biol Toxicol; 2023 Oct; 39(5):2113-2131. PubMed ID: 35218467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
    Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
    Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
    Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K
    Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin ameliorates pressure overload-induced cardiac hypertrophy by attenuating Atg5-dependent autophagy and activating the Akt/mTOR pathway.
    Xu CN; Kong LH; Ding P; Liu Y; Fan ZG; Gao EH; Yang J; Yang LF
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165848. PubMed ID: 32473999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice.
    Cao HJ; Fang J; Zhang YL; Zou LX; Han X; Yang J; Yan X; Li PB; Wang HX; Guo SB; Li HH
    J Mol Cell Cardiol; 2019 Dec; 137():34-45. PubMed ID: 31629736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway.
    Zhao D; Wang W; Wang H; Peng H; Liu X; Guo W; Su G; Zhao Z
    Int J Biol Sci; 2017; 13(3):276-285. PubMed ID: 28367092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
    Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
    J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
    Shi JY; Chen C; Xu X; Lu Q
    Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR30 Alleviates Pressure Overload-Induced Myocardial Hypertrophy in Ovariectomized Mice by Regulating Autophagy.
    Zhang S; Ma J; Wang X; Zhao D; Zhang J; Jiang L; Duan W; Wang X; Hong Z; Li Z; Liu J
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway.
    Ma H; Ge Y; Di C; Wang X; Qin B; Wang A; Hu W; Lai Z; Xiong X; Qi R
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
    Salatzki J; Foryst-Ludwig A; Bentele K; Blumrich A; Smeir E; Ban Z; Brix S; Grune J; Beyhoff N; Klopfleisch R; Dunst S; Surma MA; Klose C; Rothe M; Heinzel FR; Krannich A; Kershaw EE; Beule D; Schulze PC; Marx N; Kintscher U
    PLoS Genet; 2018 Jan; 14(1):e1007171. PubMed ID: 29320510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathway.
    Sun TL; Li WQ; Tong XL; Liu XY; Zhou WH
    Eur J Pharmacol; 2021 Jan; 891():173690. PubMed ID: 33127362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
    Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways.
    Chen Y; Liu Z; Hu Z; Feng X; Zuo L
    Bioengineered; 2022 Apr; 13(4):8323-8333. PubMed ID: 35311628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
    Xu X; Su YL; Shi JY; Lu Q; Chen C
    Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
    Xia G; Fan F; Liu M; Wang S; Wu J; Shen C; Han S; Wang C; Jia J; Zou Y; Hu K; Ge J; Sun A
    Biochim Biophys Acta; 2016 Sep; 1862(9):1587-93. PubMed ID: 27239698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
    Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W
    BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation.
    Xie X; Bi HL; Lai S; Zhang YL; Li N; Cao HJ; Han L; Wang HX; Li HH
    Sci Adv; 2019 May; 5(5):eaau0495. PubMed ID: 31086810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.